Onconaut Therapeutics, Inc. — Form D

Onconaut Therapeutics, Inc. of AURORA, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-04. The offering totals $125K, of which $125K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-11-04
• Form: D
• Accession: 0002042684-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $125K
• Amount sold: $125K
• Investors: 1
• Date of first sale: 2024-10-21
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-528575

Issuer

• Name: Onconaut Therapeutics, Inc.
• CIK: 0002042684
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 27604 E. EUCLID DRIVE, AURORA, CO, 80016
• Phone: (000) 000-0000

Officers, directors & promoters (3)

More

• CIK 2042684 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search